KIFFIK Biomedical Inc. – Visionary science. Game-changing potential

At KIFFIK we believe that the body is constantly talking to us and that Interstitial Fluid (ISF) is our body’s information superhighway. Communicating through biomarkers, ISF lets us access health signals to transform and personalize diagnostics and beyond.

Revolutionizing diagnostics through the power of isf

PARTNER WITH US

*The KIFFIK Lab is not FDA cleared. For investigational use only.

A new kind of health platform.

Remote.
Real-time.
Remarkably human.

At KIFFIK, we believe the human body is more than a machine to be managed. It sends us continuous health signals in the form of biomarkers. These are designed to guide us, to help us understand our health. But accessing ISF and this valuable data has remained out of reach for broad use.

Introducing the KIFFIK Lab™

Our proprietary platform unlocks the diagnostic power of interstitial fluid — easily, safely, and with precision.

Watch to learn more about the KIFFIk Lab.

The power of Interstitial fluid
to transform healthcare

What makes the KIFFIK Lab different?

More than a test.
A platform for future diagnostics.

ISF not Blood

Patented Needle-free MOA

A Platform Engineered to Scale

Focused first on

Early cancer detection.

Tackling a global health crisis, the KIFFIK Lab enables at-home screening for Colorectal Cancer (CRC) at its earliest stages, when it is most treatable and curable.

It’s fast, clean, accurate – and it’s just the beginning.

Learn about the KIFFIK Lab CRC

The KIFFIK Lab™

Limitless potential.

ISF is the gateway to personalized, accessible health diagnostics.

Our platform is ready to power the next wave of precision health diagnostics.

Learn About Our Platform

“If we were able to measure biological target engagement directly in the fluid around the cells, we would boost the pace of discovery.”

Dr. Francesco del Galdo

Professor, Experimental Medicine, Leeds University

Join us at the forefront of
diagnostic innovation

We are looking for investors and partners ready to transform health through ISF. Let’s build the future together.

Visit Investor Center

Dermatology: Non-invasive assessment of skin inflammation, disease flares (e.g., eczema, psoriasis), and potentially early indicators of melanoma or other skin cancers

Beauty & Wellness: Real-time monitoring of skin barrier integrity, hydration, oxidative stress, and treatment response for personalized skincare routines

A new kind of health platform.

Remote. Real-time. Remarkably human.

Introducing the KIFFIK Lab™

The power of Interstitial fluidto transform healthcare

What makes the KIFFIK Lab different?

More than a test. A platform for future diagnostics.

ISF not Blood

Patented Needle-free MOA

A Platform Engineered to Scale

Focused first on

Early cancer detection.

The KIFFIK Lab™

Limitless potential.

Join us at the forefront of diagnostic innovation

Navigation

FOLLOW US

The challenge.

The opportunity.

Clinical application:

Potential biomoarkers:

Estradiol (E2)

Luteinizing Hormone (LH)

Progesterone

Follicle-Stimulating Hormone (FSH)

Anti-Müllerian Hormone (AMH)

Hormonal health shouldn’t be a guessing game. With KIFFIK, women can see their cycle, and their care, more clearly than ever before.

The challenge.

The opportunity.

Clinical application:

Potential biomoarkers:

Interleukin-6 (IL-6)

S100B (neurotrauma indicator)

Lactate (tissue hypoxia)

D-dimer (coagulation dysfunction)

Myoglobin (muscle damage)

TNF-α (systemic inflammation)

When every second counts, insight can’t wait for the hospital. KIFFIK’s platform is designed to move with the mission — delivering data where it’s needed most.

The challenge.

The opportunity.

Clinical application:

Potential biomoarkers:

Prostate-Specific Antigen (PSA)

PCA3 (Prostate Cancer Antigen 3)

Alpha-methylacyl-CoA racemase (AMACR)

Circulating tumor DNA (ctDNA) for mutation profiling

Interleukin-8 (IL-8) and other inflammation markers

Continuous insight without constant disruption, KIFFIK’s platform enables smarter, patient-centered care for prostate cancer across the spectrum of disease.

The challenge.

The opportunity.

Clinical application:

Potential biomoarkers:

IL-6, CRP (inflammatory signaling)

Adiponectin, leptin (metabolic regulation)

VEGF, IL-8 (oncogenic pathways)

S100B, GFAP (neuroinflammatory injury)

Every breakthrough begins with better data. KIFFIK gives researchers a new lens on human biology, continuously, painlessly, and in real time.

The challenge.

The opportunity.

Clinical application:

Potential biomoarkers:

Procalcitonin (PCT)

C-reactive protein (CRP)

Interleukin-6 (IL-6)

TNF-α (Tumor Necrosis Factor-alpha)

Lactate

When sepsis moves fast, we have to move faster. KIFFIK’s platform could help detect the warning signs before symptoms spiral.

The challenge.

The opportunity.

Clinical application:

Potential biomoarkers:

Interleukin-1α (IL-1α)

Interleukin-8 (IL-8)

TNF-α

MMP-9 (Matrix metalloproteinase-9)

Reactive oxygen species (ROS)

Natural moisturizing factor (NMF) markers

The skin is always speaking — through irritation, inflammation, and subtle shifts. With ISF, we can finally hear it clearly, and respond in real time.

The challenge.

The opportunity.

Clinical application:

Remote.
Real-time.
Remarkably human.

The power of Interstitial fluid
to transform healthcare

More than a test.
A platform for future diagnostics.

Join us at the forefront of
diagnostic innovation